Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. - Wikidata - wikimedia - TriplyDB

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

http://www.wikidata.org/entity/Q34506613

about

Tamoxifen Resistance: Emerging Molecular Targets The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients Roles for miRNAs in endocrine resistance in breast cancer Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis Decoding the usefulness of non-coding RNAs as breast cancer markers ApoptomiRs of Breast Cancer: Basics to Clinics MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential The IL-4/STAT6 signaling axis establishes a conserved microRNA signature in human and mouse macrophages regulating cell survival via miR-342-3p Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Prognostic and predictive biomarkers: tools in personalized oncology.Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Identification and characterization of novel and differentially expressed microRNAs in peripheral blood from healthy and mastitis Holstein cattle by deep sequencing.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway miRNA - Therapeutic tool in breast cancer? Where are we now?MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer Critical analysis of the potential for microRNA biomarkers in breast cancer management.MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.miRNAs and estrogen action.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.The role of microRNAs in breast cancer migration, invasion and metastasis Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer.In silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers.Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

P2860

Q26739969-352C078D-6F97-4DBC-A111-1A84A58AD27E Q26782449-523A1179-DE33-4206-AC03-AB1FFB587502 Q26783076-151634F7-9774-4D64-A5BD-355D33402185 Q27011221-A7568985-E6B8-4F60-9B4F-F824C609909D Q27011401-403D90C2-3864-4D1A-BAC2-0787D0C575D0 Q28069370-2A52B741-F077-4350-A897-6A77721C2A27 Q28072414-D9BC69B7-B9B5-4EDF-9A7A-4727FF5A4759 Q28081081-ED7E08F6-202C-4DC7-AC1F-587BE38BDD52 Q28395556-36C9BCB9-632A-47A6-A6CA-AE5F1DEF1B7B Q28397240-536488CF-1F5E-4305-B9B2-C7E398CC29C5 Q28816965-AE0DCD4B-D650-452F-90E5-B4EEE5A42C3D Q33585094-0D606EC5-E550-48B0-9C94-AC73CD4B59FC Q33651583-5A062D14-D040-4918-BD63-39AF63EA320A Q34539750-573473B8-B59B-40BF-9520-F253AD6A93FF Q34664043-25532721-295E-44C8-A76E-45663C7729F8 Q34756694-39623AE0-C830-4B92-807F-60F19AB9E7EB Q34984068-D3340B22-92A5-44E1-AB0B-B73A9A60F3AF Q35024073-1BA5F8EE-E0E4-43D4-8C8F-7E2E6283B134 Q35039281-59DE79AA-14E2-4BAF-AC39-BEBAE3AFDB04 Q35059627-A1A0F212-04BD-4A21-B246-C26829508A7F Q35094742-17424F3B-6478-435E-B3C9-5D12A29AD81E Q35097232-A48A0E01-D36A-485D-8EA0-2015A4584694 Q35113386-37450190-66DE-4733-A81E-2546C8144E51 Q35128098-B5B8B295-5290-4C23-B844-4C3D1906884A Q35137273-5F3F1E09-AD18-4756-90D0-A4E4FDDC09C2 Q35144274-0FBD7402-C03C-4907-B339-CBC57D362775 Q35562595-94CA6081-7776-4C63-9AB6-4D06102F27C9 Q35709636-392D84E3-6807-4EF8-8607-A451105850B9 Q35912303-20934076-E37F-4340-BEFB-BC78B6141D59 Q35932634-D8B455B0-C9DA-4F43-9AA7-AECBEDBC443D Q35946984-410F522C-A6D0-44AF-88AB-080C9E29BD22 Q36005098-3344F757-D1C4-472E-965A-9BABAD5A24A9 Q36181081-055C2816-C2ED-4B00-A21E-F934CC12A9C1 Q36396579-3B812CB9-A5EB-4C53-94E6-F33BA8AE6CA9 Q36405766-0EEAB3BE-1A0C-4BA6-A70D-D26118D54395 Q36589865-34A9A8E1-D97B-41E6-930C-91FA34153A70 Q36603816-CAC0AC68-DA71-4DD1-9ABE-CC659AF1380E Q36629870-27B65A42-5D6E-46AA-A00F-AF1CCD283C56 Q36630868-15FA1DC6-77E3-4BF5-8778-849BE94986BB Q36636769-316478E7-D7DA-4019-B61E-BE01501DD3E0

P2860

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

http://www.wikidata.org/entity/Q34506613

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@ast

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@en

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@nl

type

label

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@ast

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@en

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@nl

prefLabel

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@ast

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@en

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

@nl

P1433

Q34506613-40859646-86AB-4277-A6CA-E27C89C2EF5D

P1476

Q34506613-418FE108-F1FD-45FD-B1DB-669BAD7570EC

P2093

Q34506613-705E3CEF-0E33-48C0-B0D0-10924D62CCB8

Q34506613-7C3ADD77-4108-4056-8266-4594383FF949

Q34506613-C130E880-BB78-417E-B103-5443DBAF569D

Q34506613-CAF88C46-F6CA-49D8-A4B5-1B15F4281C12

Q34506613-E458C78B-F622-48B8-BB1B-90062EBEA284

Q34506613-F8AFF7A1-12DE-4637-9A1B-188C54CC4AB8

P2860

Q34506613-042DE57B-C658-428D-8F33-83E39FE96CCF

Q34506613-08FCFB58-4C68-4E1F-995D-E8ADE4FB8016

Q34506613-115A5D92-8535-4D3D-B82E-4C17771451A5

Q34506613-1959E2CE-12E5-413E-878A-B9127E775CBB

Q34506613-25848769-39C9-4E45-85AC-21F1473C4427

Q34506613-297C60BF-004C-4836-9428-12E5E306FB1C

Q34506613-3928E695-D1CB-4629-955D-E77DC2EE2E85

Q34506613-3EB39853-8047-44B8-8BF5-9B640CFE7015

Q34506613-4994CEC1-3023-4358-A72F-3E515E748B59

Q34506613-49A09733-39DA-4305-BDD0-4C69EBB7688B

P2888

Q34506613-E409FC9B-6EF0-44B9-9E1F-F5DB1912DF71

P304

Q34506613-F1CAD959-D91E-4802-97AA-DC96BCC86074

P31

Q34506613-1026E842-301A-42FD-80B8-A29803D7C820

P356

Q34506613-1F8F86F9-E516-4721-A952-8E7E5219B9B2

P478

Q34506613-A98BA633-342E-4FC1-B42C-9406B71C15EA

P50

Q34506613-D7B1B304-26FC-4447-B64B-CFE07E9C47C8

P577

Q34506613-97D1510D-283E-4989-923C-E2B40340220A

P5875

Q34506613-F8F766CE-E09A-4A0C-9629-3779C99EDC53

P6179

Q34506613-BBF10DE9-A66D-40FF-A524-CF2CF26F5A0A

P698

Q34506613-90473083-54B7-497B-8919-E5EF997412D6

P932

Q34506613-31951148-CD26-4F4B-9CF4-33F2014508B5

P356

1476-4598-9-317

P1433

Molecular Cancer

P1476

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

@en

P2093

Ann D Thor

http://www.w3.org/2001/XMLSchema#string

Frank E Jones

http://www.w3.org/2001/XMLSchema#string

Jennifer K Richer

http://www.w3.org/2001/XMLSchema#string

Nicole S Spoelstra

http://www.w3.org/2001/XMLSchema#string

Partha M Das

http://www.w3.org/2001/XMLSchema#string

Susan M Edgerton

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

Switching from repression to activation: microRNAs can up-regulate translation

VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function

Genes that mediate breast cancer metastasis to lung

P2888

1476-4598-9-317

P304

317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-9-317

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Diana M Cittelly

P577

2010-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49696529

http://www.w3.org/2001/XMLSchema#string

P6179

1048874377

http://www.w3.org/2001/XMLSchema#string

P698

21172025

http://www.w3.org/2001/XMLSchema#string

P932

3024251

http://www.w3.org/2001/XMLSchema#string